Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee
Clinical trial NCT03285646 · TERMINATED
Trial details
- NCT number
- NCT03285646
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-30
- Primary completion
- 2018-05-05
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.